Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01351129 | Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers | PHASE1 | COMPLETED | 12 | — | — | May 1, 2011 | Jun 1, 2011 | Jul 6, 2011 | 1 | Singapore |
| Arm | Type | Description |
|---|---|---|
| Formulation 1 | EXPERIMENTAL | - |
| Formulation 2 | EXPERIMENTAL | - |
| Formulation 3 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Formulation 1 | DRUG | 150-mg immediate release tablet (single dose) |
| Formulation 2 | DRUG | 150-mg modified release capsule, short duration (single dose) |
| Formulation 3 | DRUG | 150-mg modified release capsule, long duration (single dose) |
Inclusion Criteria: * Healthy male and/or female (non-childbearing potential) subjects between the ages of 21 and 55 years, inclusive. * Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight \>50 kg (110 lbs). * An informed consent document signed and dated by the subject. Exclusion...